Drugs / HRV PCV-free liquid vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02914184 | Oct 2016 → Jun 2018 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRV PCV-free liquid vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02914184 ↗ |
| Modality | Vaccine | “oral live attenuated human rotavirus (HRV) vaccine” NCT02914184 ↗ |
| Route | Oral | “The vaccine will be administered orally” NCT02914184 ↗ |